Clinical predictors of multidrug-resistant Gram-negative pyogenic liver abscess and nomogram construction: A

Ke Xu1, Dong-Hui Wu1, Chu-Jia Zeng1

  • 1Graduate School, Xuzhou Medical University, Xuzhou 221006, Jiangsu Province, China.

PubMed
Abstract

Insights

Multidrug-resistant Gram-negative bacteria (MDR-GNB) are increasingly causing pyogenic liver abscesses (PLAs). Age over 60, diabetes, malignancy, low C-reactive protein, and prolonged prothrombin time predict MDR-GNB PLAs, aiding early targeted treatment.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Microbiology

Background:

  • Pyogenic liver abscesses (PLAs) are increasingly caused by multidrug-resistant (MDR) Gram-negative bacteria (GNB), notably Klebsiella pneumoniae and Escherichia coli.
  • This trend necessitates a better understanding of clinical characteristics and risk factors for MDR-GNB-related PLAs.

Purpose of the Study:

  • To identify clinical characteristics and risk factors associated with MDR-GNB-related PLAs.
  • To develop a predictive nomogram for personalized risk assessment of MDR-GNB PLAs.
  • To improve the timeliness of empirical antibiotic selection for PLAs.

Main Methods:

  • Retrospective analysis of 268 patients with Gram-negative PLAs, divided into MDR (105 patients) and non-resistant (163 patients) groups.
  • Multivariate stepwise regression modeling was used to establish a predictive nomogram based on demographic, laboratory, and prognostic indicators.
  • Statistical analysis included independent-sample t-tests, Wilcoxon rank-sum tests, and chi-squared or Fisher's exact tests.

Main Results:

  • MDR-GNB accounted for 39% of PLAs, primarily Klebsiella pneumoniae (43%) and Escherichia coli (42%).
  • Independent predictors for MDR-GNB PLAs identified were: age ≥ 60 years, diabetes, malignant tumor, lower C-reactive protein levels, and prolonged prothrombin time.
  • A nomogram was developed integrating these five predictors for individualized risk assessment.

Conclusions:

  • Age over 60, diabetes, malignant tumor, lower C-reactive protein, and higher prothrombin time levels can predict MDR-GNB infections in PLAs.
  • Early screening based on these factors can guide more targeted antibiotic treatments.
  • Further multicenter, prospective studies are needed to validate the generalizability of the predictive model.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
291
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
163
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
170
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
254
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
447